EU regulator says Russia yet to submit Covid-19 vaccine application
Coronavirus chronicle
10 February, 2021, 09:55 pm
Last modified: 10 February, 2021, 09:56 pm
European Medicines Agency said the vaccine's developers have expressed an interest that their shot be considered for a real-time review in Europe
FILE PHOTO: A handout photo shows an employee demonstrating vials with "Gam-Covid-Vac" vaccine against the coronavirus disease (Covid-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), during its production at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. Picture taken August 7, 2020. The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS
Europe's medicines regulator said on Wednesday it has so far not received any application seeking approval of the Sputnik V Covid-19 vaccine developed by Russia's Gamaleya institute.
However, the European Medicines Agency said the vaccine's developers have expressed an interest that their shot be considered for a real-time review in Europe.
The regulator said it was in discussions with Gamaleya to map out next steps.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.